Cargando…
Genes associated with anhedonia: a new analysis in a large clinical trial (GENDEP)
A key feature of major depressive disorder (MDD) is anhedonia, which is a predictor of response to antidepressant treatment. In order to shed light on its genetic underpinnings, we conducted a genome-wide association study (GWAS) followed by investigation of biological pathway enrichment using an an...
Autores principales: | Ren, Hongyan, Fabbri, Chiara, Uher, Rudolf, Rietschel, Marcella, Mors, Ole, Henigsberg, Neven, Hauser, Joanna, Zobel, Astrid, Maier, Wolfgang, Dernovsek, Mojca Z., Souery, Daniel, Cattaneo, Annamaria, Breen, Gerome, Craig, Ian W., Farmer, Anne E., McGuffin, Peter, Lewis, Cathryn M., Aitchison, Katherine J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6089928/ https://www.ncbi.nlm.nih.gov/pubmed/30104601 http://dx.doi.org/10.1038/s41398-018-0198-3 |
Ejemplares similares
-
Suicidal ideation during treatment of depression with escitalopram and nortriptyline in Genome-Based Therapeutic Drugs for Depression (GENDEP): a clinical trial
por: Perroud, Nader, et al.
Publicado: (2009) -
Candidate Genes Expression Profile Associated with Antidepressants Response in the GENDEP Study: Differentiating between Baseline ‘Predictors' and Longitudinal ‘Targets'
por: Cattaneo, Annamaria, et al.
Publicado: (2013) -
Antidepressant drug-specific prediction of depression treatment outcomes from genetic and clinical variables
por: Iniesta, Raquel, et al.
Publicado: (2018) -
Sexual dysfunction during treatment with serotonergic and noradrenergic antidepressants: Clinical description and the role of the 5-HTTLPR
por: Strohmaier, Jana, et al.
Publicado: (2011) -
Exploring the role of drug-metabolising enzymes in antidepressant side effects
por: Hodgson, Karen, et al.
Publicado: (2015)